All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sitesPotential first and only ...

BUFFALO, N.Y. – Adults with concussion or mild traumatic brain injury (TBI) who are seen in the primary care setting or discharged from the emergency department are often told to wait to see if their ...

Collaboration Aims to Develop First Intranasal Therapy for Mild Traumatic Brain Injury Aka Concussion, Establishing a Comprehensive Test-to-Treat Platform SARASOTA, Fla. and RICHMOND, Va., Feb. 11, ...

Sport-related concussions are mild traumatic brain injuries that demand timely recognition and management. This review explores current evidence on pathophysiology, diagnosis, and treatment strategies ...

The Phase IIa trial is a randomized, placebo-controlled study evaluating the safety, tolerability, and preliminary clinical signals of ONP-002 in patients presenting with acute concussion and mild ...

Oragenics submitted its Investigator's Brochure for ONP-002, preparing for a Phase II trial for mild traumatic brain injury. Oragenics, Inc., a biotechnology company based in Sarasota, Florida, ...

The Centers for Disease Control and Prevention has issued guidelines for the first time on treating children with concussions, saying they will provide doctors with the "tools they need to ensure the ...

SAN DIEGO--(BUSINESS WIRE)--Two studies by scientists at Hospital for Special Surgery (HSS) offer possible insights into treating mild traumatic brain injury (mTBI), including a potential blood ...

Hello Psychology Today readers. I'm excited to be blogging here. I was like you once -- living a full life, enjoying dinners with friends, laughing at my pets' antics, helping out and being helped by ...

Brandon-based functional neurology clinic introduces a structured fly-in rehabilitation program for post-concussion ...

FIRST SITE INITIATION VISIT COMPLETED IN AUSTRALIA SARASOTA, Fla., March 12, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering brain-tar ...